Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Chembio Diagnostics Inc. (CEMI)

4.86   0.1 (2.1%) 10-01 09:23
Open: 4.75 Pre. Close: 4.76
High: 4.935 Low: 4.67
Volume: 1,795,274 Market Cap: 103M
Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The company is headquartered in Hauppauge, New York and currently employs 295 full-time employees. The firm's products available are rapid tests for the detection of human immunodeficiency virus (HIV) 1/2 antibodies, and a multiplex rapid test for the detection of HIV and Syphilis antibodies. The HIV 1/2 rapid tests employ in-licensed and lateral flow technologies that are used with all blood matrices as samples, and are manufactured in a standard cassette format, a dipstick format and a barrel format. Its HIV 1/2 rapid antibody detection test incorporates the Dual Path Platform (DPP) POCT technology. The DPP HIV 1/2 Assay detects antibodies to HIV 1 and 2 in oral fluid samples, as well as in all blood matrices. The firm's product pipeline includes a multiplex rapid test for earlier detection of HIV and a multiplex test that detects HIV and Syphilis specific antibodies.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 4.847 - 4.867 4.867 - 4.887
Low: 4.573 - 4.593 4.593 - 4.613
Close: 4.787 - 4.822 4.822 - 4.858

Technical analysis

as of: 2020-09-30 4:39:44 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 5.76     One year: 6.73
Support: Support1: 3.81    Support2: 3.12
Resistance: Resistance1: 4.93    Resistance2: 5.76
Pivot: 4.42
Moving Average: MA(5): 4.55     MA(20): 4.25
MA(100): 6.07     MA(250): 5.79
MACD: MACD(12,26):     Signal(9): -0.10
Stochastic oscillator: %K(14,3): 90.39     %D(3): 80.44
RSI: RSI(14): 55.90
52-week: High: 15.89  Low: 2.25  Change(%): -16.2
Average Vol(K): 3-Month: 485595  10-Days: 188587

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
CEMI has closed below upper band by 13.5%. Bollinger Bands are 67.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to CEMI's normal range. The bands have been in this narrow range for 58 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Mon, 28 Sep 2020
Why Chembio Diagnostics Inc. (CEMI)’s Most Recent Report Reveals Some Hints About Its Future - The News Heater

Mon, 28 Sep 2020
Why Buy stock in Chembio Diagnostics, Inc. (CEMI)? - Marketing Sentinel

Fri, 25 Sep 2020
Do Analysts Expect Chembio Diagnostics Inc (CEMI) Stock to Rise? - InvestorsObserver

Thu, 24 Sep 2020
Chembio Diagnostics Inc. (CEMI) is on the roll with an average volume of 5.28M in the recent 3 months - The InvestChronicle

Wed, 23 Sep 2020
Chembio Diagnostics Inc (CEMI) Stock: Buy, Hold, or Sell? - InvestorsObserver

Tue, 15 Sep 2020
Why is Chembio Diagnostics Inc. (CEMI) down -35.52% from the day 1 this year? - The InvestChronicle

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 20
Shares Float (M) 18
% Held by Insiders 19.10
% Held by Institutions 42.04
Shares Short (K) 4,780
Shares Short P. Month (K) 5,360

Stock Financials

EPS -1.171
EPS Est This Year -0.520
EPS Est Next Year -0.200
Book Value (p.s.) 1.920
Profit Margin -73.26
Operating Margin -61.12
Return on Assets (ttm) -17.8
Return on Equity (ttm) -61.5
Qtrly Rev. Growth -48.3
Gross Profit (p.s.) 0.175
Sales Per Share 1.389
EBITDA (p.s.) -0.753
Qtrly Earnings Growth
Operating Cash Flow (M) -9
Levered Free Cash Flow (M) -6

Stock Valuations

PE Ratio -4.12
PEG Ratio
Price to Book value 2.51
Price to Sales 3.47
Price to Cash Flow -10.46

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.